Do levetiracetam (Keppra) or phenytoin (Dilantin) effectively stop seizures associated with alcohol withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Neither Keppra (levetiracetam) nor Dilantin (phenytoin) effectively stops alcohol withdrawal seizures

Phenytoin (Dilantin) has been definitively shown to be ineffective for preventing alcohol withdrawal seizures, and levetiracetam (Keppra) lacks evidence supporting its use in this specific context. Benzodiazepines remain the only evidence-based treatment for alcohol withdrawal seizures.

The Evidence Against Phenytoin

Multiple high-quality randomized controlled trials have directly addressed phenytoin's role in alcohol withdrawal seizures with consistent negative results:

  • A 1994 prospective, randomized, double-blind trial of 100 patients found no significant difference between phenytoin and placebo: 20.4% seizure recurrence with phenytoin versus 23.5% with placebo (P = 0.706) 1

  • A 1991 prospective, randomized, placebo-controlled study showed similar results: 21% recurrence with phenytoin versus 19% with placebo, with no statistically significant difference 2

  • A 2021 systematic review confirmed that phenytoin does not have evidence of effectiveness at preventing withdrawal seizures in the ED 3

The mechanism explains the failure: alcohol withdrawal seizures result from acute GABA receptor downregulation and glutamate upregulation, not the chronic neuronal hyperexcitability that phenytoin targets through sodium channel blockade.

The Absence of Evidence for Levetiracetam

While levetiracetam shows efficacy in status epilepticus (discussed below), there is no specific evidence supporting its use for alcohol withdrawal seizures:

  • A 2022 systematic review and meta-analysis specifically examining anti-seizure medications in alcohol withdrawal syndrome found no evidence to support general first-line clinical use of any ASMs, including levetiracetam 4

  • The 2022 ESETT trial subset analysis included only 11 patients with alcohol withdrawal-related status epilepticus treated with levetiracetam, showing 100% success (3/3 patients), but this tiny sample size prevents meaningful conclusions 5

  • The FDA label for levetiracetam makes no mention of alcohol withdrawal seizures as an indication 6

What Actually Works: Benzodiazepines

The 2021 systematic review explicitly states: "Benzodiazepines are the most evidence-based treatment for alcohol withdrawal in the ED" 3. Benzodiazepines work through GABA-A receptor agonism, directly counteracting the pathophysiology of alcohol withdrawal.

Important Clinical Distinction: Status Epilepticus vs. Withdrawal Seizures

If an alcohol withdrawal seizure progresses to status epilepticus (seizure lasting >5 minutes or recurrent seizures without return to baseline), the treatment paradigm changes entirely:

For Benzodiazepine-Refractory Status Epilepticus:

After optimal benzodiazepine dosing fails, second-line agents become appropriate. The 2014 ACEP guidelines 7 show:

  • Levetiracetam (30-50 mg/kg IV): 44-73% efficacy in various studies, with favorable safety profile (minimal hypotension/respiratory depression)
  • Valproate (20-30 mg/kg IV): 68-88% efficacy, comparable to phenytoin
  • Phenytoin/Fosphenytoin (18-20 mg/kg IV): 56-88% efficacy but significant adverse effects (hypotension, cardiac dysrhythmias, purple glove syndrome)

The 2024 ACEP guideline update 8 reinforces these options for status epilepticus specifically.

Common Pitfalls to Avoid

  1. Do not use phenytoin for alcohol withdrawal seizure prophylaxis - it is ineffective and exposes patients to unnecessary adverse effects

  2. Do not confuse alcohol withdrawal seizures with status epilepticus - they require different treatment approaches

  3. Do not withhold benzodiazepines in favor of ASMs for alcohol withdrawal - benzodiazepines are the only proven therapy

  4. Do not assume levetiracetam's efficacy in other seizure types translates to alcohol withdrawal - the pathophysiology is fundamentally different

Clinical Algorithm

For isolated alcohol withdrawal seizures:

  • Treat with benzodiazepines (lorazepam 2-4 mg IV or diazepam 5-10 mg IV)
  • Observe for 6 hours
  • Do NOT add phenytoin or levetiracetam for prophylaxis

If seizures progress to status epilepticus (>5 minutes or recurrent):

  • Optimize benzodiazepine dosing first
  • If refractory, consider second-line agents: levetiracetam (30-50 mg/kg IV) or valproate (20-30 mg/kg IV) preferred over phenytoin due to better safety profile 7

References

Related Questions

What is the optimal treatment for alcohol withdrawal seizures?
In an awake adult with traumatic brain injury, intracranial hemorrhage and skull fracture, what oral medications should be started for seizure prophylaxis, analgesia, and stress‑ulcer prophylaxis, and when can chronic oral medications be resumed?
In an adult with a hemorrhagic brain contusion and no renal impairment or prior seizure disorder, should levetiracetam (Keppra) be used for seizure prophylaxis, and what dosing and duration are appropriate?
What is the next step in managing a patient with progressive seizures on Keppra (levetiracetam) 500 mg twice a day and dexamethasone 4 mg?
How should I manage a 2.5‑year‑old girl (~14.5 kg) who developed frequent blinking movements after starting levetiracetam (Keppra) for a seizure two weeks ago?
Can you provide an example of a clinical pathway document for autoimmune hemolytic anemia (AIHA) in a hospital setting?
What is the appropriate management for post‑streptococcal glomerulonephritis?
What are the indications, dosing guidelines, contraindications, and monitoring requirements for Mycophenolate mofetil?
What is the current medical consensus on screening mammography recommendations for average‑risk women?
What are the Jones criteria for diagnosing rheumatic fever and what is the recommended management, including antibiotic therapy, anti‑inflammatory treatment, and secondary prophylaxis?
What is the significance of the Doppler gradient on echocardiography for a ventricular septal defect and how should it guide management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question